Clinical Trial Update: Sugammadex and Decreased Time to Extubation [Phase 4]

View source ↗

Summary

A Phase 4 trial updates on sugammadex and reduced time to extubation in patients undergoing coronary artery bypass graft and/or aortic valve replacement surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Replacement
• Coronary Artery Bypass Grafting

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Yale University | Conditions: Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery | Phase 4 | Status: COMPLETED | Results posted: 2022-01-14